About Naslund Medical
Naslund Medical AB is a privately held medical products company focused on the improved management and care of patients receiving radiation therapy. As the pioneer and leader in developing new technology for fiducial markers, Naslund Medical AB markets Gold Anchor worldwide. Gold Anchor enables quicker and more effective radiation therapy treatment with increased patient safety. Naslund Medical AB is based in Sweden with a subsidiary in the U.S. and contracted distributors on a global level.
Owner and inventor
Ingemar Naslund, M.D, Ph.D. Associate professor in Oncology
The Gold Anchor has been invented and developed by Ingemar Naslund, M.D, Associate Professor, working as head of the Division of Radiation Theraphy, Radiumhemmet, Karolinska University Hospital, Stockholm, Sweden for 20 years, where he was one of the inventors of the SBRT technique in 1991 together with Ingmar Lax and Henric Blomgren.
Naslund Medical AB
14139 Huddinge, Sweden
Phone: +46 706 105 411
Fax: +46 850 900 381
Naslund Medical Inc.
150 N Michigan Ave, Suite 1950
Chicago, IL 60601, USA
Phone: (312) 212 3470
Fax: (312) 277 6688
Quality Management System
Naslund Medical AB is certified to SS-EN ISO 13485:2012 and according to the Directive 93/42/EEC on Medical Devices, Annex II, Full Quality Assurance System.
Exhibitions and Events
We look forward to meet with you at an upcoming event. Or maybe we already met some of your colleagues at these recent meetings?
|PTCOG 57||May 23-25, 2018||Cincinnati, Ohio||Link|
|AUA, American Urological Association||May 18-21, 2018||San Francisco, California||Link|
|ARS, American Radium Society, 100th Annual meeting||May 5-8, 2018||Orlando, Florida||Link|
|ESTRO 37||April 20-24, 2018||Barcelona, Spain||Link|
|NAPT, The National Proton Conference||March 25-28, 2018||Scottsdale, Arizona||Link|
|2017 RSS Annual Scientific Meeting (the Radiosurgery Society)||November 2-4, 2017||Las Vegas, NV, USA||Link|
|PTCOG-NA||October 23-25, 2017||Chicago, IL, USA||Link|
|ASTRO||September 24-26, 2017||San Diego, CA, USA||Link|
|UKRCO||June 12-14, 2017||Manchester, United Kingdom||Link|
|PTCOG 56||May 11-13, 2017||Yokohama, Kanagawa, Japan||Link|
|ARS 99th Annual Meeting (American Radium Society)||May 6-9, 2017||Colorado Springs, CO, USA||Link|
|ESTRO 36||May 5-8, 2017||Vienna, Austria||Link|
|Sjuksköterskor i Cancervård||April 27-28, 2017||Stockholm, Sweden||Link|
|Finska Strålbehandlingsdagarna (Finnish Radiotherapy Days)||April 6-7, 2017||Helsinki, Finland||Link|
|Proton Therapy Congress||March 29-30, 2017||Amsterdam, the Netherlands||Link|
|NCoBC2017: The 27th Annual Interdisciplinary Breast Center Conference||March 11-13, 2017||Las Vegas, NV, USA||Link|
|NACP symposium (Nordic Association for Clinical Physics)||February 6-8, 2017||Oslo, Norway||Link|
|ASTRO’s 58th Annual Meeting||September 25-27, 2016||Boston, MA, USA. Booth #702||Link|
|The SRS/SBRT Scientific Meeting 2016||June 16-18, 2016||Orlando, FL, USA. Booth||Link|
|ESTRO 35||April 29-May 3, 2016||Turin, Italy. Booth #1800||Link|
|2016 Genitourinary Cancers Symposium||January 7-9, 2016||San Francisco, CA, USA||Link|
|JASTRO’s 28th Annual Meeting||November 19-21, 2015||Beisia Culture Hall, Maebashi, Japan||Link|
|ASTRO’s 57th Annual Meeting||October 18-21, 2015||San Antonio, TX, USA. Booth #702||Link|
Partnership with academia & healthcare
Swedish Testbed for Innovative Radiotherapy
Naslund Medical is one of the partners in a consortium aiming at establishing a Swedish testbed for innovative radiotherapy. The testbed will allow healthcare and industry to test new technology and new methods in clinical settings – and jointly drive the development of cancer treatment with radiation therapy. Learn more >
Since all cancer treatment have adverse effects on the patient, we have to do it right the first time for every individual patient, this increases the chance of cure without harming the patient – “Gentle therapy”.
Naslund Medical is one of the business partners in a consortium consisting of all teaching hospitals associated with academia and 7 important industrial companies. The long-term goal is to create a large-scale national world class platform for cancer treatment. Learn more >
Subscribe to our newsletter
Do you want to keep updated about Gold Anchor? Product development, exhibitions, testimonials. Sign up for our newsletter.